Exact Mass: 283.0908

Exact Mass Matches: 283.0908

Found 138 metabolites which its exact mass value is equals to given mass value 283.0908, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Guanosine

2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C10H13N5O5 (283.0917)


Guanosine (G), also known as 2-amino-inosine, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl sugar moiety. Guanosine consists of a guanine base attached to a ribose (ribofuranose) ring via a beta-N9-glycosidic bond. Guanosine is a white, crystalline powder with no odor and mild saline taste. It is very soluble in acetic acid, and slightly soluble in water, but insoluble in ethanol, diethyl ether, benzene, and chloroform. Guanosine exists in all living species, ranging from bacteria to plants to humans. High levels of guanosine can be found in clovers, coffee plants, and the pollen of pines. It has been detected, but not quantified in, several different foods, such as leeks, garlic, chicory roots, green bell peppers, and black-eyed peas. Guanosine plays an important role in various biochemical processes including the synthesis of nucleic acids such as RNA and intracellular signal transduction (cGMP). The antiviral drug acyclovir, often used in herpes treatment, and the anti-HIV drug abacavir, are both structurally similar to guanosine. Guanosine can be phosphorylated to become guanosine monophosphate (GMP), cyclic guanosine monophosphate (cGMP), guanosine diphosphate (GDP), and guanosine triphosphate (GTP). In humans, guanosine is involved in intracellular signalling through the adenosine receptors A1R and A2AR (PMID: 31847113). Evidence from rodent and cell models has shown a number of important neurotrophic and neuroprotective effects of guanosine. In particular, it is effective in preventing deleterious consequences of seizures, spinal cord injury, pain, mood disorders and aging-related diseases, such as ischemia, Parkinson‚Äôs and Alzheimer‚Äôs diseases (PMID: 27699087). Studies with rodent models of Parkinson‚Äôs disease have shown that guanosine decreases neuronal apoptotic cell death and increases dopaminergic neurons at substantia nigra pars compacta, accompanied by an improvement of motor symptoms in Parkinson‚Äôs disease (i.e. a reduction of bradykinesia). Guanosine promotes neurite arborization, outgrowth, proliferation and differentiation. Systemic administration of guanosine for eight weeks (8 mg/kg) has been shown to stimulate neuroprogenitors proliferation in the subventricular zone (SVZ) in a mouse model of Parkinsonism (PMID: 27699087). The effect of guanosine treatment is accompanied by an increased number of fibroblast growth factor (FGF-2)-positive cells which is an important regulator of neuroprogenitor/stem cell proliferation, survival and differentiation (PMID: 27699087). Guanosine prevents reactive oxygen species (ROS) generation and cell death in hippocampal slices subjected to the oxygen/glucose deprivation (PMID: 31847113). Guanosine is a purine nucleoside in which guanine is attached to ribofuranose via a beta-N(9)-glycosidic bond. It has a role as a fundamental metabolite. It is a purines D-ribonucleoside and a member of guanosines. It is functionally related to a guanine. Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine can be phosphorylated to become GMP (guanosine monophosphate), cGMP (cyclic guanosine monophosphate), GDP (guanosine diphosphate) and GTP (guanosine triphosphate) which are factors in signal transduction pathways. Guanosine is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Guanosine is a natural product found in Ulva australis, Allium chinense, and other organisms with data available. Guanosine is a purine nucleoside formed from a beta-N9-glycosidic bond between guanine and a ribose ring and is essential for metabolism. Guanosine is a metabolite found in or produced by Saccharomyces cerevisiae. A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed) Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a beta-N9-glycosidic bond. Guanosine can be phosphorylated to become GMP (guanosine monophosphate), cGMP (cyclic guanosine monophosphate), GDP (guanosine diphosphate) and GTP (guanosine triphosphate). ; The nucleoside guanosine exert important neuroprotective and neuromodulator roles in the central nervous system, which may be related to inhibition of the glutamatergic neurotransmission activity. Guanosine is the specific extracellular guanine-based purines effector and indicate that its conversion occurs not only in the central nervous system but also peripherally. (PMID: 16325434); Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a ?-N9-glycosidic bond. Guanosine is found in many foods, some of which are elderberry, malus (crab apple), acerola, and arrowhead. A purine nucleoside in which guanine is attached to ribofuranose via a beta-N(9)-glycosidic bond. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS [Spectral] Guanosine (exact mass = 283.09167) and 3,4-Dihydroxy-L-phenylalanine (exact mass = 197.06881) and Glutathione disulfide (exact mass = 612.15196) and AMP (exact mass = 347.06308) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] Guanosine (exact mass = 283.09167) and Guanine (exact mass = 151.04941) and 3,4-Dihydroxy-L-phenylalanine (exact mass = 197.06881) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. Acquisition and generation of the data is financially supported in part by CREST/JST. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.125 CONFIDENCE standard compound; INTERNAL_ID 317 KEIO_ID G015; [MS2] KO008966 Annotation level-2 KEIO_ID G015 Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity. Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity. Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity.

   

Crotonosid

6-amino-9-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-3H-purin-2(9H)-one;9-?-D-Ribofuranosylisoguanine

C10H13N5O5 (283.0917)


Crotonoside is a purine nucleoside. Crotonoside is a natural product found in Croton tiglium with data available. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 26 Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1]. Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1]. Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1].

   

Avenanthramide 1p

2-{[(2E)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}benzoate

C16H13NO4 (283.0845)


Avenanthramide 1p is a polyphenol compound found in foods of plant origin (PMID: 20428313)

   

8-Hydroxy-deoxyguanosine

2-amino-8-hydroxy-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C10H13N5O5 (283.0917)


8-hydroxy-deoxyguanosine (8-OHdG) is a sensitive marker of the DNA damage due to hydroxyl radical attack at the C8 of guanine. This damage, if left unrepaired, has been proposed to contribute to mutagenicity and cancer promotion. 8-OHdG has also been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID: 22626821). 8-hydroxy-deoxyguanosine (8-OHdG) is a sensitive marker of the DNA damage due to hydroxyl radical attack at the C8 of guanine. This damage, if left unrepaired, has been proposed to contribute to mutagenicity and cancer promotion. [HMDB] 8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis. 8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis.

   

(E)-Avenanthramide D

2-{[(2Z)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}benzoate

C16H13NO4 (283.0845)


(E)-Avenanthramide D is found in cereals and cereal products. (E)-Avenanthramide D is isolated from the oat Avena sativa. Isolated from the oat Avena sativa. (E)-Avenanthramide D is found in oat and cereals and cereal products.

   

9-beta-d-Arabinofuranosylguanine

2-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H13N5O5 (283.0917)


   

8-Hydroxy-2-desoxyguanosine

2-amino-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,7,8,9-tetrahydro-1H-purine-6,8-dione

C10H13N5O5 (283.0917)


   

Cariporide

4-Isopropyl-3-(methylsulfonyl)benzoyl-guanidine methanesulfonate

C12H17N3O3S (283.0991)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

hydroxydeoxyguanosine

2-amino-9-[2,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C10H13N5O5 (283.0917)


   

1-[(2R,5R)-4-Azidooxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione

1-[4-(azidooxy)-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H13N5O5 (283.0917)


   

2-Amino-9-[(2R,4S,5R)-5-(hydroperoxymethyl)-4-hydroxyoxolan-2-yl]-1H-purin-6-one

2-amino-9-[5-(hydroperoxymethyl)-4-hydroxyoxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C10H13N5O5 (283.0917)


   
   
   
   
   

Maybridge2_000294

Maybridge2_000294

C13H17NO4S (283.0878)


   
   
   
   
   
   

salinosporamide C

salinosporamide C

C14H18ClNO3 (283.0975)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

O-acetylursuline

O-acetylursuline

C16H13NO4 (283.0845)


   

5-deoxy-7-methylbostrycoidin

5-deoxy-7-methylbostrycoidin

C16H13NO4 (283.0845)


   

Oxytrofalcatin D

Oxytrofalcatin D

C16H13NO4 (283.0845)


   
   

Asiaticumine A

Asiaticumine A

C16H13NO4 (283.0845)


   
   

Aristolactam AIIIa

Aristolactam AIIIa

C16H13NO4 (283.0845)


   
   

6,7-Dimethoxycleistopholine

6,7-Dimethoxycleistopholine

C16H13NO4 (283.0845)


   
   
   

Virstatin

4-(1,3-dioxobenzo[de]isoquinolin-2-yl)butanoic acid

C16H13NO4 (283.0845)


   

8-oxo-2-Deoxyguanosine

8-hydroxy-2-deoxyguanosine

C10H13N5O5 (283.0917)


8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis. 8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis.

   

Guanosine

Guanosine

C10H13N5O5 (283.0917)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; NYHBQMYGNKIUIF_STSL_0162_Guanosine_0500fmol_180430_S2_LC02_MS02_164; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I.; MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040 Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity. Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity. Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity.

   
   

Crotonoside

6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-1H-purin-2-one

C10H13N5O5 (283.0917)


Purines Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1]. Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1]. Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1].

   

Guanosine; LC-tDDA; CE10

Guanosine; LC-tDDA; CE10

C10H13N5O5 (283.0917)


   

Guanosine; LC-tDDA; CE20

Guanosine; LC-tDDA; CE20

C10H13N5O5 (283.0917)


   

Guanosine; LC-tDDA; CE30

Guanosine; LC-tDDA; CE30

C10H13N5O5 (283.0917)


   

Guanosine; LC-tDDA; CE40

Guanosine; LC-tDDA; CE40

C10H13N5O5 (283.0917)


   

8-Hydroxy-deoxyguanosine

8-Hydroxy-deoxyguanosine

C10H13N5O5 (283.0917)


   

4-NAPHTHALIMIDOBUTYRIC ACID

4-NAPHTHALIMIDOBUTYRIC ACID

C16H13NO4 (283.0845)


   

8-hydroxy-2-deoxy Guanosine

8-hydroxy-2-deoxy Guanosine

C10H13N5O5 (283.0917)


   

Avenanthramide D

2-[(2E)-3-(4-hydroxyphenyl)prop-2-enamido]benzoic acid

C16H13NO4 (283.0845)


   

(E)-Avenanthramide D

2-[(2Z)-3-(4-hydroxyphenyl)prop-2-enamido]benzoic acid

C16H13NO4 (283.0845)


   

3-amino-4-(2-methoxyphenoxy)benzotrifluoride

3-amino-4-(2-methoxyphenoxy)benzotrifluoride

C14H12F3NO2 (283.082)


   

3-[4-(PYRROLIDIN-1-YLSULFONYL)PHENYL]PROPANOIC ACID

3-[4-(PYRROLIDIN-1-YLSULFONYL)PHENYL]PROPANOIC ACID

C13H17NO4S (283.0878)


   

4-[(3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL)METHYL]BENZOIC ACID

4-[(3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL)METHYL]BENZOIC ACID

C16H13NO4 (283.0845)


   

5-(tert-Butoxycarbonyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid

5-(tert-Butoxycarbonyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid

C13H17NO4S (283.0878)


   

4-METHYL-3-(PIPERIDINE-1-SULFONYL)BENZOICACID

4-METHYL-3-(PIPERIDINE-1-SULFONYL)BENZOICACID

C13H17NO4S (283.0878)


   

4-methylsulfanyl-2-[(2-phenoxyacetyl)amino]butanoic acid

4-methylsulfanyl-2-[(2-phenoxyacetyl)amino]butanoic acid

C13H17NO4S (283.0878)


   

L-Guanosine

L-Guanosine

C10H13N5O5 (283.0917)


L-Guanosine is the L-configuration of Guanosine (HY-N0097). Guanosine is a purine nucleoside with anti-herpesvirus activity[1][2].

   

4-[(2-METHYLPIPERIDIN-1-YL)SULFONYL]BENZOIC ACID

4-[(2-METHYLPIPERIDIN-1-YL)SULFONYL]BENZOIC ACID

C13H17NO4S (283.0878)


   

1-[(4-methoxyphenyl)methyl]-5-nitroindazole

1-[(4-methoxyphenyl)methyl]-5-nitroindazole

C15H13N3O3 (283.0957)


   

4-(Bromomethyl)-2,6-di-tert-butylpyridine

4-(Bromomethyl)-2,6-di-tert-butylpyridine

C14H22BrN (283.0936)


   

N-[2-Amino-4-chloro-6-[[(1R,4S)-4-(hydroxymethyl)-2-cyclopenten-1-yl]amino]-5-pyrimidinyl]formamide

N-[2-Amino-4-chloro-6-[[(1R,4S)-4-(hydroxymethyl)-2-cyclopenten-1-yl]amino]-5-pyrimidinyl]formamide

C11H14ClN5O2 (283.0836)


   

2-(4-Methoxybenzyloxy)-5-(trifluoromethyl)pyridine

2-(4-Methoxybenzyloxy)-5-(trifluoromethyl)pyridine

C14H12F3NO2 (283.082)


   

Resorufin butyrate

Resorufin butyrate

C16H13NO4 (283.0845)


   

papaveroline

papaveroline

C16H13NO4 (283.0845)


C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

   

3-Piperidinecarboxylicacid, 4-oxo-1-phenyl-, ethyl ester, hydrochloride (1:1)

3-Piperidinecarboxylicacid, 4-oxo-1-phenyl-, ethyl ester, hydrochloride (1:1)

C14H18ClNO3 (283.0975)


   

Ara-G

9-beta-d-Arabinofuranosylguanine

C10H13N5O5 (283.0917)


D000970 - Antineoplastic Agents 9-β-D-Arabinofuranosylguanine is a Guanosine (HY-N0097) analog and shows high affinity for deoxyguanosine kinase (dGK) with a Km of 8.0 μM. 9-β-D-Arabinofuranosylguanine can be used for the research of T-cell lymphoblastic disease[1][2].

   

Benzoic acid,2-[[(2-oxo-2-phenylethyl)amino]carbonyl]-

Benzoic acid,2-[[(2-oxo-2-phenylethyl)amino]carbonyl]-

C16H13NO4 (283.0845)


   

4,7-Dihydro-5H-thieno[2,3-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl ester

4,7-Dihydro-5H-thieno[2,3-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl ester

C13H17NO4S (283.0878)


   

N-[4-(PIPERAZINE-1-SULFONYL)-PHENYL]-ACETAMIDE

N-[4-(PIPERAZINE-1-SULFONYL)-PHENYL]-ACETAMIDE

C12H17N3O3S (283.0991)


   

Boc-(4-aminophenylthio)acetic acid

Boc-(4-aminophenylthio)acetic acid

C13H17NO4S (283.0878)


   

2-[(2-METHOXYBENZOYL)AMINO]-4-(METHYLTHIO)BUTANOIC ACID

2-[(2-METHOXYBENZOYL)AMINO]-4-(METHYLTHIO)BUTANOIC ACID

C13H17NO4S (283.0878)


   

2-(1,1-DIOXIDOTHIOMORPHOLINO)-3-PHENYLPROPANOIC ACID

2-(1,1-DIOXIDOTHIOMORPHOLINO)-3-PHENYLPROPANOIC ACID

C13H17NO4S (283.0878)


   

6-(TERT-BUTOXYCARBONYL)-4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID

6-(TERT-BUTOXYCARBONYL)-4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID

C13H17NO4S (283.0878)


   

3-Amino-4-(4-methoxyphenoxy)benzotrifluoride

3-Amino-4-(4-methoxyphenoxy)benzotrifluoride

C14H12F3NO2 (283.082)


   

1-ISOPROPYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

1-ISOPROPYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C15H13N3O3 (283.0957)


   

7-PHENYL-1-PROPYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

7-PHENYL-1-PROPYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C15H13N3O3 (283.0957)


   

2-(benzyloxycarbonyl)-2-(isopropylthio)acetic acid

2-(benzyloxycarbonyl)-2-(isopropylthio)acetic acid

C13H17NO4S (283.0878)


   

2-Azido-2-deoxy-5-methyluridine

2-Azido-2-deoxy-5-methyluridine

C10H13N5O5 (283.0917)


   

1-(TOLUENE-4-SULFONYL)-PIPERIDINE-3-CARBOXYLIC ACID

1-(TOLUENE-4-SULFONYL)-PIPERIDINE-3-CARBOXYLIC ACID

C13H17NO4S (283.0878)


   

Diethyl 6,7-dihydrothieno[3,2-c]pyridine-2,5(4H)-dicarboxylate

Diethyl 6,7-dihydrothieno[3,2-c]pyridine-2,5(4H)-dicarboxylate

C13H17NO4S (283.0878)


   

Methyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride

Methyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride

C14H18ClNO3 (283.0975)


   
   

4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE

4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE

C12H18ClN3OSi (283.0908)


   
   

(E)-METHYL 4-(4-NITROSTYRYL)BENZOATE

(E)-METHYL 4-(4-NITROSTYRYL)BENZOATE

C16H13NO4 (283.0845)


   
   

2-CYANO-3-(TRIFLUOROMETHYL)PHENYL BORONIC ACID NEOPENTYL GLYCOL ESTER

2-CYANO-3-(TRIFLUOROMETHYL)PHENYL BORONIC ACID NEOPENTYL GLYCOL ESTER

C13H13BF3NO2 (283.0991)


   

ALPHA,ALPHA-IMINODI-P-TOLUNITRILE HYDROCHLORIDE

ALPHA,ALPHA-IMINODI-P-TOLUNITRILE HYDROCHLORIDE

C16H14ClN3 (283.0876)


   

2-[(2-chloroacetyl)-(2,6-diethylphenyl)amino]acetic acid

2-[(2-chloroacetyl)-(2,6-diethylphenyl)amino]acetic acid

C14H18ClNO3 (283.0975)


   

4-Nitrophenyl 2-(trimethylsilyl)ethyl carbonate

4-Nitrophenyl 2-(trimethylsilyl)ethyl carbonate

C12H17NO5Si (283.0876)


   

2-(4-CHLORO-PHENYL)-5-P-TOLYL-2H-PYRAZOL-3-YLAMINE

2-(4-CHLORO-PHENYL)-5-P-TOLYL-2H-PYRAZOL-3-YLAMINE

C16H14ClN3 (283.0876)


   

1-[(4-methylphenyl)sulfonyl]-4-piperidinecarboxylic acid

1-[(4-methylphenyl)sulfonyl]-4-piperidinecarboxylic acid

C13H17NO4S (283.0878)


   

4-(Azepan-1-ylsulfonyl)benzoic acid

4-(Azepan-1-ylsulfonyl)benzoic acid

C13H17NO4S (283.0878)


   

Adenosine N1-oxide

Adenosine N1-oxide

C10H13N5O5 (283.0917)


   

Guanine, 9-beta-D-xylofuranosyl-

Guanine, 9-beta-D-xylofuranosyl-

C10H13N5O5 (283.0917)


D000970 - Antineoplastic Agents

   

N-cyclohexyl-2-(2-thienylcarbonyl)-1-hydrazinecarbothioamide

N-cyclohexyl-2-(2-thienylcarbonyl)-1-hydrazinecarbothioamide

C12H17N3OS2 (283.0813)


   

2H-Pyrano[3,2-g]quinolin-2-one, 6,7,8,9-tetrahydro-9-methyl-4-(trifluoromethyl)-

2H-Pyrano[3,2-g]quinolin-2-one, 6,7,8,9-tetrahydro-9-methyl-4-(trifluoromethyl)-

C14H12F3NO2 (283.082)


   

9-Hydroxy-7-methoxy-3,8-dimethylbenzo[g]isoquinoline-5,10-dione

9-Hydroxy-7-methoxy-3,8-dimethylbenzo[g]isoquinoline-5,10-dione

C16H13NO4 (283.0845)


   

N-(2-fluorophenyl)-6-(1,2,4-triazol-1-yl)-3-pyridinecarboxamide

N-(2-fluorophenyl)-6-(1,2,4-triazol-1-yl)-3-pyridinecarboxamide

C14H10FN5O (283.0869)


   

N-[(3-chlorophenyl)methyl]-4-methylphthalazin-1-amine

N-[(3-chlorophenyl)methyl]-4-methylphthalazin-1-amine

C16H14ClN3 (283.0876)


   

3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide

3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide

C14H10FN5O (283.0869)


   

N-(5-luoro-4-iminoquinazolin-3-yl)pyridine-4-carboxamide

N-(5-luoro-4-iminoquinazolin-3-yl)pyridine-4-carboxamide

C14H10FN5O (283.0869)


   

3-[2-(dimethylazaniumyl)ethyl]-1H-indol-4-yl phosphate

3-[2-(dimethylazaniumyl)ethyl]-1H-indol-4-yl phosphate

C12H16N2O4P- (283.0848)


   
   

8-Hydroxy-2-desoxyguanosine

8-Hydroxy-2-desoxyguanosine

C10H13N5O5 (283.0917)


   

2-amino-9-[2,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one

2-amino-9-[2,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one

C10H13N5O5 (283.0917)


   

1-[(2R,5R)-4-Azidooxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione

1-[(2R,5R)-4-Azidooxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione

C10H13N5O5 (283.0917)


   

2-Amino-9-[(2R,4S,5R)-5-(hydroperoxymethyl)-4-hydroxyoxolan-2-yl]-1H-purin-6-one

2-Amino-9-[(2R,4S,5R)-5-(hydroperoxymethyl)-4-hydroxyoxolan-2-yl]-1H-purin-6-one

C10H13N5O5 (283.0917)


   

N-[(2-hydroxyphenyl)-oxomethyl]-2,3-dihydrobenzofuran-5-carboxamide

N-[(2-hydroxyphenyl)-oxomethyl]-2,3-dihydrobenzofuran-5-carboxamide

C16H13NO4 (283.0845)


   

2-Ethyl-6-fluoro-7-(1-piperazinyl)-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one

2-Ethyl-6-fluoro-7-(1-piperazinyl)-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one

C11H14FN5OS (283.0903)


   

arabinofuranosylguanine

arabinofuranosylguanine

C10H13N5O5 (283.0917)


   

4-(4-Chlorophenoxy)-1-(4-morpholinyl)-1-butanone

4-(4-Chlorophenoxy)-1-(4-morpholinyl)-1-butanone

C14H18ClNO3 (283.0975)


   

6-Methyl-4-(trifluoromethyl)-7,8,9,10-tetrahydropyrano[2,3-f]quinolin-2-one

6-Methyl-4-(trifluoromethyl)-7,8,9,10-tetrahydropyrano[2,3-f]quinolin-2-one

C14H12F3NO2 (283.082)


   

2-(2,5-dioxo-4-imidazolidinyl)-N-(1-naphthalenyl)acetamide

2-(2,5-dioxo-4-imidazolidinyl)-N-(1-naphthalenyl)acetamide

C15H13N3O3 (283.0957)


   

4-(3-Methoxyphenyl)-4-methyl-2,6-dioxopiperidine-3,5-dicarbonitrile

4-(3-Methoxyphenyl)-4-methyl-2,6-dioxopiperidine-3,5-dicarbonitrile

C15H13N3O3 (283.0957)


   

2-chloro-N-[(1R)-1-phenylethyl]-4-quinazolinamine

2-chloro-N-[(1R)-1-phenylethyl]-4-quinazolinamine

C16H14ClN3 (283.0876)


   

5-[(E)-2-(2,6-difluorophenyl)ethenyl]quinolin-8-ol

5-[(E)-2-(2,6-difluorophenyl)ethenyl]quinolin-8-ol

C17H11F2NO (283.0809)


   

4-Methylphenyl beta-D-glucopyranosiduronate

4-Methylphenyl beta-D-glucopyranosiduronate

C13H15O7- (283.0818)


   

N-{[3,5-dimethyl-4-(methylthio)phenoxy]carbonyl}-beta-alanine

N-{[3,5-dimethyl-4-(methylthio)phenoxy]carbonyl}-beta-alanine

C13H17NO4S (283.0878)


   

8-hydroxy-2-deoxyguanosine

8-hydroxy-2-deoxyguanosine

C10H13N5O5 (283.0917)


8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis. 8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis.

   

psilocybin(1-)

psilocybin(1-)

C12H16N2O4P (283.0848)


An organophosphate oxoanion resulting from the protons from the phosphate group and the protonation of the tertiary amino group of psilocybin. The major species at pH 7.3

   
   

p-tolyl beta-D-glucuronide(1-)

p-tolyl beta-D-glucuronide(1-)

C13H15O7 (283.0818)


A carbohydrate acid derivative anion resulting from the removal of a proton from the carboxy group of p-tolyl beta-D-glucuronide.

   
   

8-Hydroxyadenosine

8-Hydroxyadenosine

C10H13N5O5 (283.0917)


8-Hydroxyadenosine is a purine nucleoside[1].

   

2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}benzoic acid

2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}benzoic acid

C16H13NO4 (283.0845)


   

7,8-dimethoxy-4-methylbenzo[g]quinoline-5,10-dione

7,8-dimethoxy-4-methylbenzo[g]quinoline-5,10-dione

C16H13NO4 (283.0845)


   

(2s,3r,4s,5s)-2-(6-hydroxy-2-imino-3h-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2s,3r,4s,5s)-2-(6-hydroxy-2-imino-3h-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H13N5O5 (283.0917)


   

(4ar,8as,9s,9as)-2-(2-chloroethyl)-9-hydroxy-1-methyl-4ah,5h,7h,8h,8ah,9h,9ah-cyclohexa[b]pyrrolizine-3,6-dione

(4ar,8as,9s,9as)-2-(2-chloroethyl)-9-hydroxy-1-methyl-4ah,5h,7h,8h,8ah,9h,9ah-cyclohexa[b]pyrrolizine-3,6-dione

C14H18ClNO3 (283.0975)


   

11-methoxy-5-methyl-2h-[1,3]dioxolo[4,5-b]acridin-10-one

11-methoxy-5-methyl-2h-[1,3]dioxolo[4,5-b]acridin-10-one

C16H13NO4 (283.0845)


   

1-(4-hydroxybenzoyl)-3-methoxyindol-4-ol

1-(4-hydroxybenzoyl)-3-methoxyindol-4-ol

C16H13NO4 (283.0845)


   

2-{[(2e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}benzoic acid

2-{[(2e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}benzoic acid

C16H13NO4 (283.0845)


   

3-methoxy-1,4-dimethylbenzo[g]quinoline-2,5,10-trione

3-methoxy-1,4-dimethylbenzo[g]quinoline-2,5,10-trione

C16H13NO4 (283.0845)


   

n-[5-(4-ethenylphenoxycarbonyl)-2-hydroxyphenyl]carboximidic acid

n-[5-(4-ethenylphenoxycarbonyl)-2-hydroxyphenyl]carboximidic acid

C16H13NO4 (283.0845)


   

4-methoxy-11-methyl-2h-[1,3]dioxolo[4,5-c]acridin-6-one

4-methoxy-11-methyl-2h-[1,3]dioxolo[4,5-c]acridin-6-one

C16H13NO4 (283.0845)


   

(1s)-1-{9h-[1,3]dioxolo[4,5-j]phenanthridin-4-yl}ethane-1,2-diol

(1s)-1-{9h-[1,3]dioxolo[4,5-j]phenanthridin-4-yl}ethane-1,2-diol

C16H13NO4 (283.0845)


   

1-{9h-[1,3]dioxolo[4,5-j]phenanthridin-4-yl}ethane-1,2-diol

1-{9h-[1,3]dioxolo[4,5-j]phenanthridin-4-yl}ethane-1,2-diol

C16H13NO4 (283.0845)


   

(3s,4r,5s)-2-(6-amino-2-hydroxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(3s,4r,5s)-2-(6-amino-2-hydroxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H13N5O5 (283.0917)


   

2-(6-amino-2-hydroxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

2-(6-amino-2-hydroxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H13N5O5 (283.0917)


   

8-oxo-2'-deoxyguanosine

8-oxo-2'-deoxyguanosine

C10H13N5O5 (283.0917)


   

2-(2-chloroethyl)-9-hydroxy-1-methyl-4ah,5h,7h,8h,8ah,9h,9ah-cyclohexa[b]pyrrolizine-3,6-dione

2-(2-chloroethyl)-9-hydroxy-1-methyl-4ah,5h,7h,8h,8ah,9h,9ah-cyclohexa[b]pyrrolizine-3,6-dione

C14H18ClNO3 (283.0975)